News

Aubry Daerden Enriches Crowell & Moring's Team in Brussels

Aubry Daerden Enriches Crowell & Moring's Team in Brussels

Aubry Daerden Enhances Crowell & Moring's Brussels Office

Strengthens cross-border transactional capabilities

BRUSSELS / -- Aubry Daerden has joined Crowell & Moring's Brussels office as a partner in the Corporate Group, expanding the firm's capability to represent clients on complex corporate transactions in Belgium and the EU.

Daerden brings a proven track record of managing both cross-border and domestic deals, including strategic mergers and acquisitions, private equity transactions, and joint ventures across various sectors such as life sciences, healthcare, transportation, and infrastructure. His expertise extends to aiding emerging technology companies, venture capital firms, and corporate investors throughout all stages of investment.

According to Thomas De Meese, co-managing partner of the firm's Brussels office, "Aubry's addition to our team enhances our ability to serve clients navigating sophisticated corporate matters. His deep transactional experience and commercial mindset will provide significant value to our clients and further our commitment to excellence in client service."

John Koenigsknecht, chair of Crowell's Corporate Group, expressed, "We are delighted to welcome Aubry to our corporate team. With over a decade of experience in mergers and acquisitions and private equity, he brings valuable insights and skills to our practice. He has advised clients globally across many industries, including life sciences transactions, which is a key area where we have recently expanded our capabilities. His arrival supports our strategic goal of enhancing our corporate transactional capabilities in Brussels and London, broadening our reach in key European markets."

With a background that includes pivotal roles in landmark Belgian transactions over the past decade, Daerden is also known for supporting clients making investments in Luxembourg. Leveraging his in-depth knowledge of the French market, he has been instrumental in numerous high-profile Belgian-French cross-border deals, working frequently with CAC 40 companies and private equity sponsors in France concerning their interests in the Benelux region. Alongside his transactional practice, he serves as a trusted advisor to family shareholders, private companies, and trade associations on governance, compliance, and various corporate law matters.

Reflecting on his new role, Daerden stated, "I am honored to join Crowell, a high-caliber law firm with some of the brightest legal minds in Brussels and internationally. The firm has successfully maintained its agility and integration while expanding globally. At Crowell, I immediately felt a genuine sense of community and a culture of excellence, united by a shared vision to serve clients with the utmost standards, all while keeping a sense of humor. I look forward to assisting the firm's ongoing ambitions to expand its corporate capabilities in Europe and beyond while collaborating with clients on their strategic projects."

Daerden holds a bachelor’s degree in law and a master’s degree in private law from the Free University of Brussels, coupled with a LL.M. in international economic law from the Chinese University of Hong Kong.

Since 2023, he has been consistently recognized as a "Rising Star" in corporate law, mergers, acquisitions, and commercial matters by a leading legal publication.

About Crowell & Moring LLP

Crowell & Moring LLP is an international law firm with operations in the United States, Europe, MENA, and Asia. Leveraging extensive government, business, industry, and legal experience, the firm empowers clients to seize opportunities while providing innovative solutions for complex regulatory and policy, litigation, transactional, and intellectual property challenges. The firm is widely acknowledged for its commitment to pro bono service and its comprehensive initiatives promoting the professional and personal development of all members of the Crowell community.

Media Contact

Email: [contact email]

Frequently Asked Questions

What is the significance of Aubry Daerden joining Crowell & Moring?

Aubry Daerden's addition enhances Crowell & Moring's capabilities in handling complex corporate transactions, benefitting their clients significantly.

What is the background of Aubry Daerden?

Aubry Daerden has over a decade of experience in mergers and acquisitions and specializes in various sectors, including life sciences and healthcare.

What are Crowell & Moring's key practice areas?

The firm focuses on regulatory and policy challenges, litigation, transactional law, intellectual property, and corporate matters.

How does Crowell & Moring support professional development?

Crowell & Moring is recognized for its commitment to pro bono service and offers comprehensive programs aimed at enhancing professional growth.

What kind of clients does Aubry Daerden typically work with?

He frequently assists emerging technology companies, venture capital firms, and corporate investors, addressing their diverse investment needs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 185

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 170

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 234

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 155

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 143

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 249

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 230

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 313

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Total Voting Rights: A Crucial Overview

Updated Category News Views 192

Insights into Total Voting Rights and Capital Octopus AIM VCT plc is a company that regularly updates its shareholders regarding vital information, including total voting rights and capital structure. Current Share Capital Details As of the latest disclosure period, Octopus AIM VCT plc has an issued share capital comprising 223,655,160 Ordinary shares, each valued at 1...

Continue Reading
Understanding Market Sentiment for Bio-Techne's Stock

Updated Category News Views 130

Analyzing Bio-Techne's Market Position Bio-Techne (NYSE: TECH) has recently seen an increase in the short percent of float, now standing at 29.12% since its last report. This translates to approximately 5.08 million shares sold short, making up 3.68% of all available regular shares for trading. With the current trading volume, it would typically take about 2.66 days for...

Continue Reading
Innovative Developments in Wound Care by Kane Biotech Inc.

Updated Category News Views 120

Advancements in Wound Care from Kane Biotech Inc. WINNIPEG, Manitoba — Kane Biotech Inc. (TSX-V:KNE) is making headlines with groundbreaking clinical and scientific advancements in wound care. The company recently showcased its innovative data during the Innovations in Wound Healing Annual Meeting, an event dedicated to revolutionizing treatment in this critical field....

Continue Reading
Senior Helpers Achieves Recognition as a Leading Franchise

Updated Category News Views 178

Senior Helpers Achieves Recognition as a Leading Franchise Independent Survey Shows Franchise Owners Are Highly Satisfied with Senior Helpers' Support and Overall Performance Senior Helpers has recently been awarded the title of a Top Franchise for 2025 by Franchise Business Review (FBR). This year marks a significant milestone as it is FBR's 20th year of recognizing...

Continue Reading
Bearish Moves: What Big Players Think of Super Micro Computer

Updated Category News Views 232

Diving into Super Micro Computer's Options Landscape You gotta love this market, right? Sometimes it’s a real gut check, and right now, Super Micro Computer (NASDAQ:SMCI) is at the forefront of some, let’s say, interesting options activity. Financial giants are making bearish moves—like, big-time bearish. Our look into the options history for good ol' SMCI shook out...

Continue Reading